nodes	percent_of_prediction	percent_of_DWPC	metapath
Mafenide—Pancytopenia—Altretamine—ovarian cancer	0.0553	0.0553	CcSEcCtD
Mafenide—Bone marrow depression—Melphalan—ovarian cancer	0.0426	0.0426	CcSEcCtD
Mafenide—Disseminated intravascular coagulation—Docetaxel—ovarian cancer	0.0401	0.0401	CcSEcCtD
Mafenide—Bone marrow depression—Vinorelbine—ovarian cancer	0.0372	0.0372	CcSEcCtD
Mafenide—Blister—Vinorelbine—ovarian cancer	0.0348	0.0348	CcSEcCtD
Mafenide—Haemolytic anaemia—Chlorambucil—ovarian cancer	0.0265	0.0265	CcSEcCtD
Mafenide—Haemolytic anaemia—Melphalan—ovarian cancer	0.0231	0.0231	CcSEcCtD
Mafenide—Dermatitis bullous—Topotecan—ovarian cancer	0.0223	0.0223	CcSEcCtD
Mafenide—Burning sensation—Docetaxel—ovarian cancer	0.0206	0.0206	CcSEcCtD
Mafenide—Pancytopenia—Chlorambucil—ovarian cancer	0.0197	0.0197	CcSEcCtD
Mafenide—Pain—Carboplatin—ovarian cancer	0.0196	0.0196	CcSEcCtD
Mafenide—Dermatitis bullous—Vinorelbine—ovarian cancer	0.0191	0.0191	CcSEcCtD
Mafenide—Pancytopenia—Topotecan—ovarian cancer	0.0175	0.0175	CcSEcCtD
Mafenide—Pancytopenia—Melphalan—ovarian cancer	0.0171	0.0171	CcSEcCtD
Mafenide—Pancytopenia—Vinorelbine—ovarian cancer	0.015	0.015	CcSEcCtD
Mafenide—Haemoglobin—Topotecan—ovarian cancer	0.0148	0.0148	CcSEcCtD
Mafenide—Haemorrhage—Topotecan—ovarian cancer	0.0147	0.0147	CcSEcCtD
Mafenide—Haemoglobin—Melphalan—ovarian cancer	0.0145	0.0145	CcSEcCtD
Mafenide—Haemorrhage—Melphalan—ovarian cancer	0.0144	0.0144	CcSEcCtD
Mafenide—Bone marrow depression—Epirubicin—ovarian cancer	0.0143	0.0143	CcSEcCtD
Mafenide—Hyperventilation—Epirubicin—ovarian cancer	0.014	0.014	CcSEcCtD
Mafenide—Burning sensation—Epirubicin—ovarian cancer	0.0139	0.0139	CcSEcCtD
Mafenide—Swelling—Paclitaxel—ovarian cancer	0.0139	0.0139	CcSEcCtD
Mafenide—Blister—Epirubicin—ovarian cancer	0.0134	0.0134	CcSEcCtD
Mafenide—Bone marrow depression—Doxorubicin—ovarian cancer	0.0132	0.0132	CcSEcCtD
Mafenide—Hyperventilation—Doxorubicin—ovarian cancer	0.013	0.013	CcSEcCtD
Mafenide—Burning sensation—Doxorubicin—ovarian cancer	0.0129	0.0129	CcSEcCtD
Mafenide—Blister—Doxorubicin—ovarian cancer	0.0124	0.0124	CcSEcCtD
Mafenide—Swelling—Docetaxel—ovarian cancer	0.0118	0.0118	CcSEcCtD
Mafenide—Erythema—Vinorelbine—ovarian cancer	0.011	0.011	CcSEcCtD
Mafenide—Dermatitis bullous—Docetaxel—ovarian cancer	0.0109	0.0109	CcSEcCtD
Mafenide—Pancytopenia—Paclitaxel—ovarian cancer	0.0101	0.0101	CcSEcCtD
Mafenide—Pain—Chlorambucil—ovarian cancer	0.0101	0.0101	CcSEcCtD
Mafenide—Urticaria—Chlorambucil—ovarian cancer	0.00935	0.00935	CcSEcCtD
Mafenide—Pain—Topotecan—ovarian cancer	0.00896	0.00896	CcSEcCtD
Mafenide—Pain—Melphalan—ovarian cancer	0.00877	0.00877	CcSEcCtD
Mafenide—Pancytopenia—Docetaxel—ovarian cancer	0.00853	0.00853	CcSEcCtD
Mafenide—Haemoglobin—Paclitaxel—ovarian cancer	0.00853	0.00853	CcSEcCtD
Mafenide—Haemorrhage—Paclitaxel—ovarian cancer	0.00848	0.00848	CcSEcCtD
Mafenide—Pruritus—Chlorambucil—ovarian cancer	0.00833	0.00833	CcSEcCtD
Mafenide—Urticaria—Topotecan—ovarian cancer	0.00832	0.00832	CcSEcCtD
Mafenide—Urticaria—Melphalan—ovarian cancer	0.00815	0.00815	CcSEcCtD
Mafenide—Diarrhoea—Chlorambucil—ovarian cancer	0.00805	0.00805	CcSEcCtD
Mafenide—Pain—Vinorelbine—ovarian cancer	0.00766	0.00766	CcSEcCtD
Mafenide—Pruritus—Topotecan—ovarian cancer	0.00741	0.00741	CcSEcCtD
Mafenide—Erythema—Paclitaxel—ovarian cancer	0.00739	0.00739	CcSEcCtD
Mafenide—Dermatitis bullous—Epirubicin—ovarian cancer	0.00734	0.00734	CcSEcCtD
Mafenide—Pruritus—Melphalan—ovarian cancer	0.00726	0.00726	CcSEcCtD
Mafenide—Haemoglobin—Docetaxel—ovarian cancer	0.00723	0.00723	CcSEcCtD
Mafenide—Haemorrhage—Docetaxel—ovarian cancer	0.00719	0.00719	CcSEcCtD
Mafenide—Diarrhoea—Topotecan—ovarian cancer	0.00717	0.00717	CcSEcCtD
Mafenide—Urticaria—Vinorelbine—ovarian cancer	0.00712	0.00712	CcSEcCtD
Mafenide—Diarrhoea—Melphalan—ovarian cancer	0.00702	0.00702	CcSEcCtD
Mafenide—Dermatitis bullous—Doxorubicin—ovarian cancer	0.00679	0.00679	CcSEcCtD
Mafenide—Face oedema—Epirubicin—ovarian cancer	0.00677	0.00677	CcSEcCtD
Mafenide—Rash—Topotecan—ovarian cancer	0.00661	0.00661	CcSEcCtD
Mafenide—Dermatitis—Topotecan—ovarian cancer	0.0066	0.0066	CcSEcCtD
Mafenide—Rash—Melphalan—ovarian cancer	0.00647	0.00647	CcSEcCtD
Mafenide—Dermatitis—Melphalan—ovarian cancer	0.00646	0.00646	CcSEcCtD
Mafenide—Pruritus—Vinorelbine—ovarian cancer	0.00634	0.00634	CcSEcCtD
Mafenide—Face oedema—Doxorubicin—ovarian cancer	0.00626	0.00626	CcSEcCtD
Mafenide—Erythema—Docetaxel—ovarian cancer	0.00626	0.00626	CcSEcCtD
Mafenide—Diarrhoea—Vinorelbine—ovarian cancer	0.00613	0.00613	CcSEcCtD
Mafenide—Eosinophilia—Epirubicin—ovarian cancer	0.006	0.006	CcSEcCtD
Mafenide—Pancytopenia—Epirubicin—ovarian cancer	0.00576	0.00576	CcSEcCtD
Mafenide—Rash—Vinorelbine—ovarian cancer	0.00565	0.00565	CcSEcCtD
Mafenide—Dermatitis—Vinorelbine—ovarian cancer	0.00565	0.00565	CcSEcCtD
Mafenide—Eosinophilia—Doxorubicin—ovarian cancer	0.00555	0.00555	CcSEcCtD
Mafenide—Pancytopenia—Doxorubicin—ovarian cancer	0.00533	0.00533	CcSEcCtD
Mafenide—Pain—Paclitaxel—ovarian cancer	0.00515	0.00515	CcSEcCtD
Mafenide—Haemoglobin—Epirubicin—ovarian cancer	0.00488	0.00488	CcSEcCtD
Mafenide—Haemorrhage—Epirubicin—ovarian cancer	0.00485	0.00485	CcSEcCtD
Mafenide—Urticaria—Paclitaxel—ovarian cancer	0.00479	0.00479	CcSEcCtD
Mafenide—Haemoglobin—Doxorubicin—ovarian cancer	0.00451	0.00451	CcSEcCtD
Mafenide—Haemorrhage—Doxorubicin—ovarian cancer	0.00449	0.00449	CcSEcCtD
Mafenide—Pain—Docetaxel—ovarian cancer	0.00437	0.00437	CcSEcCtD
Mafenide—Pruritus—Paclitaxel—ovarian cancer	0.00426	0.00426	CcSEcCtD
Mafenide—Erythema—Epirubicin—ovarian cancer	0.00422	0.00422	CcSEcCtD
Mafenide—Diarrhoea—Paclitaxel—ovarian cancer	0.00412	0.00412	CcSEcCtD
Mafenide—Erythema—Doxorubicin—ovarian cancer	0.00391	0.00391	CcSEcCtD
Mafenide—Rash—Paclitaxel—ovarian cancer	0.0038	0.0038	CcSEcCtD
Mafenide—Dermatitis—Paclitaxel—ovarian cancer	0.0038	0.0038	CcSEcCtD
Mafenide—Pruritus—Docetaxel—ovarian cancer	0.00361	0.00361	CcSEcCtD
Mafenide—Diarrhoea—Docetaxel—ovarian cancer	0.0035	0.0035	CcSEcCtD
Mafenide—Rash—Docetaxel—ovarian cancer	0.00322	0.00322	CcSEcCtD
Mafenide—Dermatitis—Docetaxel—ovarian cancer	0.00322	0.00322	CcSEcCtD
Mafenide—Pain—Epirubicin—ovarian cancer	0.00295	0.00295	CcSEcCtD
Mafenide—Urticaria—Epirubicin—ovarian cancer	0.00274	0.00274	CcSEcCtD
Mafenide—Pain—Doxorubicin—ovarian cancer	0.00273	0.00273	CcSEcCtD
Mafenide—Urticaria—Doxorubicin—ovarian cancer	0.00253	0.00253	CcSEcCtD
Mafenide—Pruritus—Epirubicin—ovarian cancer	0.00244	0.00244	CcSEcCtD
Mafenide—Diarrhoea—Epirubicin—ovarian cancer	0.00236	0.00236	CcSEcCtD
Mafenide—Pruritus—Doxorubicin—ovarian cancer	0.00226	0.00226	CcSEcCtD
Mafenide—Diarrhoea—Doxorubicin—ovarian cancer	0.00218	0.00218	CcSEcCtD
Mafenide—Rash—Epirubicin—ovarian cancer	0.00217	0.00217	CcSEcCtD
Mafenide—Dermatitis—Epirubicin—ovarian cancer	0.00217	0.00217	CcSEcCtD
Mafenide—Rash—Doxorubicin—ovarian cancer	0.00201	0.00201	CcSEcCtD
Mafenide—Dermatitis—Doxorubicin—ovarian cancer	0.00201	0.00201	CcSEcCtD
